191 related articles for article (PubMed ID: 25408213)
1. Peripheral amyloid levels present gender differences associated with aging in AβPP/PS1 mice.
Ordóñez-Gutiérrez L; Antón M; Wandosell F
J Alzheimers Dis; 2015; 44(4):1063-8. PubMed ID: 25408213
[TBL] [Abstract][Full Text] [Related]
2. AβPP/PS1 Transgenic Mice Show Sex Differences in the Cerebellum Associated with Aging.
Ordoñez-Gutierrez L; Fernandez-Perez I; Herrera JL; Anton M; Benito-Cuesta I; Wandosell F
J Alzheimers Dis; 2016 Sep; 54(2):645-56. PubMed ID: 27567877
[TBL] [Abstract][Full Text] [Related]
3. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
4. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.
Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J
Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice.
Wang J; Tanila H; Puoliväli J; Kadish I; van Groen T
Neurobiol Dis; 2003 Dec; 14(3):318-27. PubMed ID: 14678749
[TBL] [Abstract][Full Text] [Related]
6. Memory Improvement in the AβPP/PS1 Mouse Model of Familial Alzheimer’s Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes.
Armand-Ugón M; Aso E; Moreno J; Riera-Codina M; Sánchez A; Vegas E; Ferrer I
J Alzheimers Dis; 2015; 45(2):407-21. PubMed ID: 25790933
[TBL] [Abstract][Full Text] [Related]
7. Calretinin interneurons are early targets of extracellular amyloid-beta pathology in PS1/AbetaPP Alzheimer mice hippocampus.
Baglietto-Vargas D; Moreno-Gonzalez I; Sanchez-Varo R; Jimenez S; Trujillo-Estrada L; Sanchez-Mejias E; Torres M; Romero-Acebal M; Ruano D; Vizuete M; Vitorica J; Gutierrez A
J Alzheimers Dis; 2010; 21(1):119-32. PubMed ID: 20413859
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of interneuron populations and correlation with amyloid-β deposition in the olfactory cortex of an AβPP/PS1 transgenic mouse model of Alzheimer's disease.
Saiz-Sanchez D; Ubeda-Bañon I; De la Rosa-Prieto C; Martinez-Marcos A
J Alzheimers Dis; 2012; 31(1):113-29. PubMed ID: 22543847
[TBL] [Abstract][Full Text] [Related]
9. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
10. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
11. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
12. Presenilin-1 adopts pathogenic conformation in normal aging and in sporadic Alzheimer's disease.
Wahlster L; Arimon M; Nasser-Ghodsi N; Post KL; Serrano-Pozo A; Uemura K; Berezovska O
Acta Neuropathol; 2013 Feb; 125(2):187-99. PubMed ID: 23138650
[TBL] [Abstract][Full Text] [Related]
13. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
[TBL] [Abstract][Full Text] [Related]
14. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
15. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
[TBL] [Abstract][Full Text] [Related]
16. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
17. Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.
Soejima N; Ohyagi Y; Nakamura N; Himeno E; Iinuma KM; Sakae N; Yamasaki R; Tabira T; Murakami K; Irie K; Kinoshita N; LaFerla FM; Kiyohara Y; Iwaki T; Kira J
Curr Alzheimer Res; 2013 Jan; 10(1):11-20. PubMed ID: 22950910
[TBL] [Abstract][Full Text] [Related]
18. Tocotrienol-Rich Fraction Modulates Amyloid Pathology and Improves Cognitive Function in AβPP/PS1 Mice.
Ibrahim NF; Yanagisawa D; Durani LW; Hamezah HS; Damanhuri HA; Wan Ngah WZ; Tsuji M; Kiuchi Y; Ono K; Tooyama I
J Alzheimers Dis; 2017; 55(2):597-612. PubMed ID: 27716672
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-β in Alzheimer's disease.
Tian L; Zhang K; Tian ZY; Wang T; Shang DS; Li B; Liu DX; Fang WG; Wang ZY; Chen YH
J Alzheimers Dis; 2014; 42(2):511-20. PubMed ID: 24898658
[TBL] [Abstract][Full Text] [Related]
20. Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse models.
Reinert J; Martens H; Huettenrauch M; Kolbow T; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Bayer TA; Wirths O
J Alzheimers Dis; 2014; 39(4):871-81. PubMed ID: 24305500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
